Movatterモバイル変換


[0]ホーム

URL:


News & Perspective
Drugs & Diseases
CME & Education
Video
Decision Point

Specialty:Multispecialty
Edition:English
Log In
Sign Up It's Free!
English Edition

Medscape

Univadis

    X
    UnivadisfromMedscape
    RegisterLog In

    No Results

      No Results

        Friday, March 28, 2025
        News & PerspectiveDrugs & DiseasesCME & EducationVideoDecision Point
        close
        Please confirm that you would like to log out of Medscape.If you log out, you will be required to enter your username and password the next time you visit.Log outCancel

        Chemical and Microbiologic Aspects of Penems, a Distinct Class of β-Lactams: Focus on Faropenem

        Jeremy M. T. Hamilton-Miller, D.Sc., FRCPath

        Disclosures

        Pharmacotherapy. 2003;23(11) 

        In This Article

        Structural Classification of Penems

        β-lactam antibiotics consist of a four-membered β-lactam ring, which may be fused to five- or six-membered heterocyclic rings (Figure 1). Heterocyclic rings may be saturated or unsaturated with a double bond positioned between positions 3 and 4, and the heteroatom in position 1 may be sulfur (penams, cephems, and penems), carbon (carbapenems and carbacephems), or oxygen (clavams, oxapenems, and oxacephems). The hydrogen atoms at C5 and C6 of the penams, and C6 and C7 of the cephems, are in thecis orientation, whereas the hydrogen atoms at C5 and C6 of carbapenems and penems are in thetrans orientation. Monobactams, a structurally distinct class of agents, consist of unfused β-lactam rings.

        Representative β-lactam ring structures. Atom numbering is illustrated for penams and cephems.

        The structural core of penem molecules is a hybrid of penicillin (penam) and cephalosporin (cephem) structures.[4,5] These hybrid β-lactam structures do not occur naturally, and production of penems is an entirely synthetic process.

        Although structurally distinct, the penems are often confused with the carbapenem class of drugs.[6,7] Penems have an unsaturated five-membered thiazoline ring with a double bond positioned between C2 and C3, fused to the β-lactam ring; a sulfur atom occupies position 1 of the heterocyclic ring (Figure 1),[8] altering the three-dimensional shape of the molecule. In contrast, carbapenems are based on the β-lactam ring fused to an unsaturated five-membered pyrolline ring with a carbon atom at position 1.

        Five main penem subgroups -- thiopenems, oxypenems, aminopenems, alkylpenems, and arylpenems -- have been produced and are distinguished by the side chain at position 2 of the unsaturated five-membered ring (Figure 2). One structurally distinct penem is BRL 42715 (Figure 2). This molecule has no substitution at position 2 but has a bulky group at position 6, and it displays effective inhibition of class C β-lactamases, but no antimicrobial activity.

        Examples of four of the five main penem subgroups and one structurally distinct penem.

        One possible consequence of these structural differences of penems from other β-lactams may be reduced immunogenicity and immunogenic cross-reactivity. Up to 10% of the population have an allergy to penicillins,[9] and approximately 10% of these people also have an allergy to cephalosporins.[10] The β-lactam rings of penicillins react with the ε amino group of lysine residues to form penicilloyl-protein antigens. In contrast, when the β-lactam rings of cephalosporins are broken in this way, the ring nucleus of the molecule usually disintegrates, leaving only the side chain at position 7 bound to the protein to determine antigenicity.[11] Penicillins and cephalosporins generally vary through their substitution at position 6 or 7, respectively, with the heterocyclic ring presenting the less variable part of these molecules. In contrast, penems are generally derivatized at position 2 in the heterocyclic ring, making this part of the molecule more variable. For this reason, reduced cross immunogenicity with penicillins and cephalosporins may be expected. Indeed, one study found low levels of cross-reactivity of antibodies against a range of β-lactams to faropenem in a rabbit model.[12]

          Pharmacotherapy. 2003;23(11) © 2003 Pharmacotherapy Publications
          Copyright © 1999,Pharmacotherapy Publications, Inc., All rights reserved.

          Cite this: Chemical and Microbiologic Aspects of Penems, a Distinct Class of β-Lactams: Focus on Faropenem - Medscape - Nov 01, 2003.

          Tables
            Table 1. Activity of β-lactams Against Important Pathogens
          DrugStaphylococcus
          aureus
          a
          Escherichia
          coli
          Streptococcus
          pneumoniae
          b
          Pseudomonas
          aeruginosa
          Moraxella
          catarrhalis
          Haemophilus
          influenzae
          Faropenem+++++++ (+)-+++
          Amoxicillin+-++++ (+/-)-++++
          Amoxicillin-clavulanate++++++ (+/-)-++++
          Cefaclor+/-+/-+ (-)-++/-
          Ceftriaxone+/-+++++ (-)-++++
          Cefotaxime+/-+++++ (-)-++++
          Cefixime-+++ (-)-++++++
          Imipenem+++++++++ (+)+/-+++++/-

          MIC90 values: ++++ = 0.008-0.015 mg/L; +++ = 0.03-0.06 mg/L; ++ = 0.12-0.25 mg/L; + = 0.05-1.0 mg/L; +/- = 2-8 mg/L; - = 16-64 mg/L.[19]
          aNot methicillin-resistantS. aureus.
          bPenicillin-resistant strains are shown in parentheses.

          Tables
            Table 2. In Vitro Activity of Faropenem Against Gram-Negative Bacteria[19]
          BacteriaNo. of
          Isolates
          MIC Range
          (mg/L)
          MIC50
          (mg/L)
          MIC90
          (mg/L)
          Haemophilus influenzae (β-lactamase negative)500.03-10.51
          Haemophilus influenzae (β-lactamase positive)200.056-10.51
          Moraxella catarrhalis (β-lactamase negative)500.015-0.50.060.5
          Moraxella catarrhalis (β-lactamase positive)20≤ 0.0075-0.060.0150.03
          Escherichia coli (AMPa ≤ 8)300.13-10.251
          Escherichia coli (AMPa > 8)580.5-211
          Pseudomonas aeruginosa50128 to > 256> 256> 256
          Salmonella sp200.25-40.51
          Shigella sp220.5-10.51
          Serratia sp201-128232
          Stenotrophomonas maltophilia10128 to > 128> 128> 128
          Neisseria gonorrhoeae350.008-0.250.030.06
          Neisseria meningitidis100.0080.0080.008

          MIC = minimum inhibitory concentration; MIC50, 90 = MIC for 50% and 90%, respectively, of tested strains.
          aMIC90 for ampicillin.

          References
          Authors and Disclosures

          Authors and Disclosures

          Jeremy M. T. Hamilton-Miller,D.Sc.,FRCPath is from the Department of Medical Microbiology, Royal Free and University College London Medical School, London, England.

          Representative β-lactam ring structures. Atom numbering is illustrated for penams and cephems.

          Examples of four of the five main penem subgroups and one structurally distinct penem.

          My Alerts

          You have already selected for My Alerts

          Click the topic below to receive emails when new articles are available.

           

          You've successfully added to your alerts. You will receive email when new content is published.

          Print
          Add to Email Alerts

          processing....

          Email This
          Feedback
          Help us make reference on Medscape the best clinical resource possible.Please use this form to submit your questions or comments on how to make this article more useful to clinicians.
          Pleasedo not use this form to submit personal or patient medical information or to report adverse drug events. You are encouraged to report adverse drug event information to the FDA.
          Your Name is required.
          Subject is required.
          Please enter a Recipient Address and/or check the Send me a copy checkbox.
          Your email has been sent.
          is an Invalid Email Address.
          Medscape Logo
          Find Us On
          About
          About MedscapePrivacy PolicyEditorial PolicyCookiesManage PreferencesTerms of UseAdvertising PolicyHelp Center
          Membership
          Become a MemberAbout YouProfessional InformationNewsletters & AlertsAdvertiseMarket Research
          Medscape
          Editions
          EnglishDeutschEspañolFrançaisPortuguês
          All material on this website is protected by copyright, Copyright © 1994-2025 by WebMD LLC. This website also contains material copyrighted by 3rd parties.

          [8]ページ先頭

          ©2009-2025 Movatter.jp